Logo image of BOXL

BOXLIGHT CORP - CLASS A (BOXL) Stock Fundamental Analysis

USA - NASDAQ:BOXL - US1031973076 - Common Stock

1.77 USD
-0.06 (-3.28%)
Last: 10/17/2025, 8:00:01 PM
1.75 USD
-0.02 (-1.13%)
After Hours: 10/17/2025, 8:00:01 PM
Fundamental Rating

2

BOXL gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 34 industry peers in the Technology Hardware, Storage & Peripherals industry. BOXL may be in some trouble as it scores bad on both profitability and health. BOXL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

BOXL had negative earnings in the past year.
In the past year BOXL had a positive cash flow from operations.
BOXL had negative earnings in each of the past 5 years.
In multiple years BOXL reported negative operating cash flow during the last 5 years.
BOXL Yearly Net Income VS EBIT VS OCF VS FCFBOXL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M -40M

1.2 Ratios

The Return On Assets of BOXL (-29.23%) is worse than 75.76% of its industry peers.
BOXL has a worse Return On Equity (-367.98%) than 69.70% of its industry peers.
Industry RankSector Rank
ROA -29.23%
ROE -367.98%
ROIC N/A
ROA(3y)-17.74%
ROA(5y)-14.46%
ROE(3y)-95.05%
ROE(5y)-65.13%
ROIC(3y)N/A
ROIC(5y)N/A
BOXL Yearly ROA, ROE, ROICBOXL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K

1.3 Margins

BOXL has a Gross Margin of 33.84%. This is in the better half of the industry: BOXL outperforms 63.64% of its industry peers.
BOXL's Gross Margin has improved in the last couple of years.
BOXL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.84%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.22%
GM growth 5Y5.07%
BOXL Yearly Profit, Operating, Gross MarginsBOXL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

More info and screens

3

2. Health

2.1 Basic Checks

BOXL does not have a ROIC to compare to the WACC, probably because it is not profitable.
BOXL has more shares outstanding than it did 1 year ago.
The number of shares outstanding for BOXL has been increased compared to 5 years ago.
Compared to 1 year ago, BOXL has a worse debt to assets ratio.
BOXL Yearly Shares OutstandingBOXL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M
BOXL Yearly Total Debt VS Total AssetsBOXL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

BOXL has an Altman-Z score of -1.57. This is a bad value and indicates that BOXL is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.57, BOXL is not doing good in the industry: 78.79% of the companies in the same industry are doing better.
BOXL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 11.1
Altman-Z -1.57
ROIC/WACCN/A
WACC13.45%
BOXL Yearly LT Debt VS Equity VS FCFBOXL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

BOXL has a Current Ratio of 0.99. This is a bad value and indicates that BOXL is not financially healthy enough and could expect problems in meeting its short term obligations.
BOXL's Current ratio of 0.99 is on the low side compared to the rest of the industry. BOXL is outperformed by 69.70% of its industry peers.
BOXL has a Quick Ratio of 0.99. This is a bad value and indicates that BOXL is not financially healthy enough and could expect problems in meeting its short term obligations.
BOXL has a Quick ratio of 0.57. This is in the lower half of the industry: BOXL underperforms 78.79% of its industry peers.
Industry RankSector Rank
Current Ratio 0.99
Quick Ratio 0.57
BOXL Yearly Current Assets VS Current LiabilitesBOXL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.12% over the past year.
BOXL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -30.79%.
The Revenue has been growing by 32.72% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)15.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
Revenue 1Y (TTM)-30.79%
Revenue growth 3Y-9.8%
Revenue growth 5Y32.72%
Sales Q2Q%-19.89%

3.2 Future

Based on estimates for the next years, BOXL will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.34% on average per year.
BOXL is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.15% yearly.
EPS Next Y63.64%
EPS Next 2Y34.67%
EPS Next 3Y22.05%
EPS Next 5Y14.34%
Revenue Next Year-22.52%
Revenue Next 2Y-11.98%
Revenue Next 3Y-6.65%
Revenue Next 5Y-2.15%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BOXL Yearly Revenue VS EstimatesBOXL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 50M 100M 150M 200M
BOXL Yearly EPS VS EstimatesBOXL Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 -10 -20 -30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

BOXL reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BOXL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BOXL Price Earnings VS Forward Price EarningsBOXL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

96.97% of the companies in the same industry are more expensive than BOXL, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 2.77
EV/EBITDA N/A
BOXL Per share dataBOXL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20

4.3 Compensation for Growth

BOXL's earnings are expected to grow with 22.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.67%
EPS Next 3Y22.05%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BOXL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BOXLIGHT CORP - CLASS A

NASDAQ:BOXL (10/17/2025, 8:00:01 PM)

After market: 1.75 -0.02 (-1.13%)

1.77

-0.06 (-3.28%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryTechnology Hardware, Storage & Peripherals
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners20.88%
Inst Owner Change0%
Ins Owners1.93%
Ins Owner Change-0.02%
Market Cap10.11M
Analysts43.33
Price Target6.38 (260.45%)
Short Float %1.18%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.65
Dividend Growth(5Y)N/A
DP-3.28%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.26%
Min EPS beat(2)-6.88%
Max EPS beat(2)19.41%
EPS beat(4)1
Avg EPS beat(4)-73.03%
Min EPS beat(4)-200.54%
Max EPS beat(4)19.41%
EPS beat(8)3
Avg EPS beat(8)-82.5%
EPS beat(12)7
Avg EPS beat(12)-41.83%
EPS beat(16)8
Avg EPS beat(16)-32.38%
Revenue beat(2)1
Avg Revenue beat(2)-3.43%
Min Revenue beat(2)-17.69%
Max Revenue beat(2)10.83%
Revenue beat(4)1
Avg Revenue beat(4)-10.5%
Min Revenue beat(4)-21.79%
Max Revenue beat(4)10.83%
Revenue beat(8)3
Avg Revenue beat(8)-7.94%
Revenue beat(12)4
Avg Revenue beat(12)-7.45%
Revenue beat(16)7
Avg Revenue beat(16)-3.84%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-237.5%
EPS NY rev (1m)-11.85%
EPS NY rev (3m)-11.85%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.81%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.09
P/FCF 2.77
P/OCF 2.59
P/B 1.24
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-13.75
EYN/A
EPS(NY)-2.71
Fwd EYN/A
FCF(TTM)0.64
FCFY36.05%
OCF(TTM)0.68
OCFY38.66%
SpS20.61
BVpS1.43
TBVpS-2.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.23%
ROE -367.98%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.84%
FCFM 3.1%
ROA(3y)-17.74%
ROA(5y)-14.46%
ROE(3y)-95.05%
ROE(5y)-65.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y11.22%
GM growth 5Y5.07%
F-Score4
Asset Turnover1.14
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 11.1
Debt/EBITDA N/A
Cap/Depr 1.18%
Cap/Sales 0.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.99
Quick Ratio 0.57
Altman-Z -1.57
F-Score4
WACC13.45%
ROIC/WACCN/A
Cap/Depr(3y)10.21%
Cap/Depr(5y)9%
Cap/Sales(3y)0.56%
Cap/Sales(5y)0.46%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-61.11%
EPS Next Y63.64%
EPS Next 2Y34.67%
EPS Next 3Y22.05%
EPS Next 5Y14.34%
Revenue 1Y (TTM)-30.79%
Revenue growth 3Y-9.8%
Revenue growth 5Y32.72%
Sales Q2Q%-19.89%
Revenue Next Year-22.52%
Revenue Next 2Y-11.98%
Revenue Next 3Y-6.65%
Revenue Next 5Y-2.15%
EBIT growth 1Y-344.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year147.77%
EBIT Next 3Y28%
EBIT Next 5Y20.17%
FCF growth 1Y-52.68%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-53.34%
OCF growth 3YN/A
OCF growth 5YN/A